Oral anti-CD3 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral anti-CD3 monoclonal antibody, covering 2011-06-23 to 2011-06-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome [Phase 2]